Relay Therapeutics (RLAY) Gains from Sales and Divestitures (2020 - 2022)
Relay Therapeutics (RLAY) reported Gains from Sales and Divestitures of $398330.0 for Q4 2022, up 424.98% year-over-year from $75875.0 in Q4 2021, and up 424.98% quarter-over-quarter from $75875.0 in Q4 2021.
Relay Therapeutics (RLAY) Gains from Sales and Divestitures (2020 - 2022) Analysis & Trends
Relay Therapeutics (RLAY) has 3 years of Gains from Sales and Divestitures data on file, last reported at $398330.0 in Q4 2022.
- Gains from Sales and Divestitures for Q4 2022 came in at $398330.0, up 424.98% year-over-year; the trailing twelve-month figure through Dec 2022 was $398330.0 (up 424.98% YoY), and the FY2022 annual result was $398330.0, up 424.98% from the prior year.
- Gains from Sales and Divestitures improved to $398330.0 in Q4 2022 per RLAY's latest filing, from $75875.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $579825.0 in Q4 2020 and troughed at $75875.0 in Q4 2021.
- A 3-year average of $351343.3 and a median of $398330.0 in 2022 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2021 and 2022: Gains from Sales and Divestitures tumbled 86.91% in 2021, then soared 424.98% in 2022.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $579825.0 in 2020, then plunged by 86.91% to $75875.0 in 2021, then soared by 424.98% to $398330.0 in 2022.
- Business Quant data shows RLAY's Gains from Sales and Divestitures at $398330.0 in Q4 2022, $75875.0 in Q4 2021, and $579825.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 398,330.00 |
| Dec 31, 2022 | 398,330.00 |
| Dec 31, 2021 | 75,875.00 |
| Dec 31, 2021 | 75,875.00 |
| Dec 31, 2020 | 579,825.00 |
| Dec 31, 2020 | 579,825.00 |